Validation of bovine glycomacropeptide as an intestinal anti-inflammatory nutraceutical in the lymphocyte-transfer model of colitis

British Journal of Nutrition

Volumn 111, Issue 7, 2014, Pages 1202-1212

  Ortega González, Mercedes ^a   Capitán Cañadas, Fermín ^a   Requena, Pilar ^a,b   Ocón, Borja ^a   Romero Calvo, Isabel ^a   Aranda, Carlos ^a   Suárez, María Dolores ^a   Zarzuelo, Antonio ^a   Sánchez De Medina, Fermín ^a   Martínez Augustin, Olga ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

Casein macropeptide; Dextran sulphate sodium; Glycomacropeptide; Inflammatory bowel disease; Lymphocyte transfer colitis

Indexed keywords

CALGRANULIN A; CD4 ANTIGEN; CONCANAVALIN A; CXCL1 CHEMOKINE; DEXTRAN SULFATE; GAMMA INTERFERON; GLYCOPROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYELOPEROXIDASE; NUTRACEUTICAL; POLYPEPTIDE ANTIBIOTIC AGENT; REGENERATING ISLET DERIVED PROTEIN 3GAMMA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CASEIN; CASEINOMACROPEPTIDE; GASTROINTESTINAL AGENT; HOMEODOMAIN PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; PEPTIDE FRAGMENT; PEROXIDASE; RAG 1 PROTEIN; RAG-1 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BOVINE; COLITIS; COLON; COLON INJURY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; ILEUM; INFLAMMATORY BOWEL DISEASE; LYMPHOCYTE TRANSFER; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; T LYMPHOCYTE; WEIGHT GAIN; ANIMAL; BLOOD; C57BL MOUSE; CATTLE; COMPARATIVE STUDY; DIET SUPPLEMENTATION; DISEASE MODEL; GENETICS; IMMUNOLOGY; INTESTINE MUCOSA; KNOCKOUT MOUSE; MESENTERIC LYMPHADENITIS; METABOLISM; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; RANDOMIZATION;

BOVINAE; MUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL MARKERS; CASEINS; CATTLE; COLON; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; FEMALE; GASTROINTESTINAL AGENTS; HOMEODOMAIN PROTEINS; ILEUM; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MESENTERIC LYMPHADENITIS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHIL INFILTRATION; PEPTIDE FRAGMENTS; PEROXIDASE; RANDOM ALLOCATION; WEIGHT GAIN;

EID: 84900514168     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114513003590     Document Type: Article

References (29)

1. Ekbom A (2004) The epidemiology of IBD: a lot of data but little knowledge. How shall we proceed? Inflamm Bowel Dis 10, Suppl. 1, S32-S34.
2. Sands BE (2007) Inflammatory bowel disease: past, present, and future. J Gastroenterol 42, 16-25.
3. Nenci A, Becker C, Wullaert A, et al. (2007) Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 446, 557-561.
4. Sainathan SK, Hanna EM, Gong Q, et al. (2008) Granulocyte macrophage colony-stimulating factor ameliorates DSSinduced experimental colitis. Inflamm Bowel Dis 14, 88-99.
5. Qualls JE, Kaplan AM, van Rooijen N, et al. (2006) Suppression of experimental colitis by intestinal mononuclear phagocytes. J Leukoc Biol 80, 802-815.
6. + dendritic cells. Inflamm Bowel Dis 15, 236-247.
7. Brody EP (2000) Biological activities of bovine glycomacropeptide. Br J Nutr 84, S39-S46.
8. Nakano T, Silva-Hernandez ER, Ikawa N, et al. (2002) Purification of kappa-casein glycomacropeptide from sweet whey with undetectable level of phenylalanine. Biotechnol Prog 18, 409-412.
9. Nakay S & Modler HW (1999) Food Proteins. Processing Applications. New York, NY: Wiley-VCH.
10. Lopez-Posadas R, Requena P, Gonzalez R, et al. (2010) Bovine glycomacropeptide has intestinal antiinflammatory effects in rats with dextran sulfate-induced colitis. J Nutr 140, 2014-2019.
11. Sánchez de Medina F, Daddaoua A, Requena P, et al. (2010) New insights into the immunological effects of food bioactive peptides in animal models of intestinal inflammation. Proc Nutr Soc 69, 454-462.
12. Requena P, Daddaoua A, Martínez-Plata E, et al. (2008) Bovine glycomacropeptide ameliorates experimental rat ileitis by mechanisms involving downregulation of interleukin 17. Br J Pharmacol 154, 825-832.
13. Daddaoua A, Puerta V, Zarzuelo A, et al. (2005) Bovine glycomacropeptide is anti-inflammatory in rats with hapten-induced colitis. J Nutr 135, 1164-1170.
14. Koboziev I, Karlsson F, Zhang S, et al. (2011) Pharmacological intervention studies using mouse models of the inflammatory bowel diseases: translating preclinical data into new drug therapies. Inflamm Bowel Dis 17, 1229-1245.
15. Pérez-Navarro R, Ballester I, Zarzuelo A, et al. (2005) Disturbances in epithelial ionic secretion in different experimental models of colitis. Life Sci 76, 1489-1501.
16. Ito H, Tanabe H, Kawagishi H, et al. (2009) Short-chain inulin-like fructans reduce endotoxin and bacterial translocations and attenuate development of TNBS-induced colitis in rats. Dig Dis Sci 54, 2100-2108.
17. Krawisz JE, Sharon P & Stenson WF (1984) Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 87, 1344-1350.
18. Lopez-Posadas R, Gonzalez R, Ballester I, et al. (2011) Tissue-nonspecific alkaline phosphatase is activated in enterocytes by oxidative stress via changes in glycosylation. Inflamm Bowel Dis 17, 543-556.
19. Ostanin DV, Bao J, Koboziev I, et al. (2009) T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade. Am J Physiol Gastrointest Liver Physiol 296, G135-G146.
20. - cell-transferred SCID mice for preclinical evaluation of drugs for inflammatory bowel disease. J Pharmacol Sci 110, 169-181.
21. Requena P, Daddaoua A, Guadix E, et al. (2009) Bovine glycomacropeptide induces cytokine production in human monocytes through the stimulation of the MAPK and the NF-kappaB signal transduction pathways. Br J Pharmacol 157, 1232-1240.
22. Fomon SJ (1993) Nutrition of Normal Infants. St Louis: Mosby Yearbook, Inc.
23. Monnai M & Otani H (1997) Effect of bovine k-caseinoglycopeptide on secretion of interleukin-1 family cytokines by P388D1 cells, a line derived from mouse monocyte/macrophage. Milchwissenschaft - Milk Sci Int 52, 192-196.
24. Otani H & Hata I (1995) Inhibition of proliferative responses of mouse spleen lymphocytes and rabbit Peyer's patch cells by bovine milk caseins and their digests. J Dairy Res 62, 339-348.
25. Monnai M, Horimoto Y & Otani H (1998) Immunomodificatory effect of dietary bovine kappa-caseinoglycopeptide on serum antibody levels and proliferative responses of lymphocytes in mice. Milchwissenschaft - Milk Sci Int 53, 129-132.
26. Cooper HS, Murthy SN, Shah RS, et al. (1993) Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 69, 238-249.
27. Morris GP, Beck PL, Herridge MS, et al. (1989) Hapteninduced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96, 795-803.
28. Grisham MB, Volkmer C, Tso P, et al. (1991) Metabolism of trinitrobenzene sulfonic acid by the rat colon produces reactive oxygen species. Gastroenterology 101, 540-547.
29. Karrasch T, Kim JS, Jang BI, et al. (2007) The flavonoid luteolin worsens chemical-induced colitis in NF-kappaB (EGFP) transgenic mice through blockade of NF-kappaB-dependent protective molecules. PLoS ONE 2, e596.